Cargando…

Towards in vivo estimation of reaction kinetics using high-throughput metabolomics data: a maximum likelihood approach

BACKGROUND: High-throughput assays such as mass spectrometry have opened up the possibility for large-scale in vivo measurements of the metabolome. This data could potentially be used to estimate kinetic parameters for many metabolic reactions. However, high-throughput in vivo measurements have spec...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Weiruo, Kolte, Ritesh, Dill, David L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595320/
https://www.ncbi.nlm.nih.gov/pubmed/26437964
http://dx.doi.org/10.1186/s12918-015-0214-7
_version_ 1782393585364107264
author Zhang, Weiruo
Kolte, Ritesh
Dill, David L
author_facet Zhang, Weiruo
Kolte, Ritesh
Dill, David L
author_sort Zhang, Weiruo
collection PubMed
description BACKGROUND: High-throughput assays such as mass spectrometry have opened up the possibility for large-scale in vivo measurements of the metabolome. This data could potentially be used to estimate kinetic parameters for many metabolic reactions. However, high-throughput in vivo measurements have special properties that are not taken into account in existing methods for estimating kinetic parameters, including significant relative errors in measurements of metabolite concentrations and reaction rates, and reactions with multiple substrates and products, which are sometimes reversible. A new method is needed to estimate kinetic parameters taking into account these factors. RESULTS: A new method, InVEst (In Vivo Estimation), is described for estimating reaction kinetic parameters, which addresses the specific challenges of in vivo data. InVEst uses maximum likelihood estimation based on a model where all measurements have relative errors. Simulations show that InVEst produces accurate estimates for a reversible enzymatic reaction with multiple reactants and products, that estimated parameters can be used to predict the effects of genetic variants, and that InVEst is more accurate than general least squares and graphic methods on data with relative errors. InVEst uses the bootstrap method to evaluate the accuracy of its estimates. CONCLUSIONS: InVEst addresses several challenges of in vivo data, which are not taken into account by existing methods. When data have relative errors, InVEst produces more accurate and robust estimates. InVEst also provides useful information about estimation accuracy using bootstrapping. It has potential applications of quantifying the effects of genetic variants, inference of the target of a mutation or drug treatment and improving flux estimation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12918-015-0214-7) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4595320
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45953202015-10-08 Towards in vivo estimation of reaction kinetics using high-throughput metabolomics data: a maximum likelihood approach Zhang, Weiruo Kolte, Ritesh Dill, David L BMC Syst Biol Methodology Article BACKGROUND: High-throughput assays such as mass spectrometry have opened up the possibility for large-scale in vivo measurements of the metabolome. This data could potentially be used to estimate kinetic parameters for many metabolic reactions. However, high-throughput in vivo measurements have special properties that are not taken into account in existing methods for estimating kinetic parameters, including significant relative errors in measurements of metabolite concentrations and reaction rates, and reactions with multiple substrates and products, which are sometimes reversible. A new method is needed to estimate kinetic parameters taking into account these factors. RESULTS: A new method, InVEst (In Vivo Estimation), is described for estimating reaction kinetic parameters, which addresses the specific challenges of in vivo data. InVEst uses maximum likelihood estimation based on a model where all measurements have relative errors. Simulations show that InVEst produces accurate estimates for a reversible enzymatic reaction with multiple reactants and products, that estimated parameters can be used to predict the effects of genetic variants, and that InVEst is more accurate than general least squares and graphic methods on data with relative errors. InVEst uses the bootstrap method to evaluate the accuracy of its estimates. CONCLUSIONS: InVEst addresses several challenges of in vivo data, which are not taken into account by existing methods. When data have relative errors, InVEst produces more accurate and robust estimates. InVEst also provides useful information about estimation accuracy using bootstrapping. It has potential applications of quantifying the effects of genetic variants, inference of the target of a mutation or drug treatment and improving flux estimation. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12918-015-0214-7) contains supplementary material, which is available to authorized users. BioMed Central 2015-10-05 /pmc/articles/PMC4595320/ /pubmed/26437964 http://dx.doi.org/10.1186/s12918-015-0214-7 Text en © Zhang et al. 2015 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Methodology Article
Zhang, Weiruo
Kolte, Ritesh
Dill, David L
Towards in vivo estimation of reaction kinetics using high-throughput metabolomics data: a maximum likelihood approach
title Towards in vivo estimation of reaction kinetics using high-throughput metabolomics data: a maximum likelihood approach
title_full Towards in vivo estimation of reaction kinetics using high-throughput metabolomics data: a maximum likelihood approach
title_fullStr Towards in vivo estimation of reaction kinetics using high-throughput metabolomics data: a maximum likelihood approach
title_full_unstemmed Towards in vivo estimation of reaction kinetics using high-throughput metabolomics data: a maximum likelihood approach
title_short Towards in vivo estimation of reaction kinetics using high-throughput metabolomics data: a maximum likelihood approach
title_sort towards in vivo estimation of reaction kinetics using high-throughput metabolomics data: a maximum likelihood approach
topic Methodology Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4595320/
https://www.ncbi.nlm.nih.gov/pubmed/26437964
http://dx.doi.org/10.1186/s12918-015-0214-7
work_keys_str_mv AT zhangweiruo towardsinvivoestimationofreactionkineticsusinghighthroughputmetabolomicsdataamaximumlikelihoodapproach
AT kolteritesh towardsinvivoestimationofreactionkineticsusinghighthroughputmetabolomicsdataamaximumlikelihoodapproach
AT dilldavidl towardsinvivoestimationofreactionkineticsusinghighthroughputmetabolomicsdataamaximumlikelihoodapproach